Phase II Trial of Paclitaxel in Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group Study

This publication has 14 references indexed in Scilit:

• Ifosfamide and Doxorubicin in the Treatment of Advanced Leiomyosarcomas of the Uterus: A Gynecologic Oncology Group Study
  Gynecologic Oncology, 1996
• A phase II trial of paclitaxel in patients with advanced soft tissue sarcomas. A southwest oncology group study
  Cancer, 1995
• Phase II study with Docetaxel (Taxotere®) in advanced soft tissue sarcomas of the adult
  Annals of Oncology, 1994
• Phase II trial of ifosfamide and mesna in leiomyosarcoma ofthe uterus: A Gynecologic Oncology Group study
  American Journal of Obstetrics and Gynecology, 1992
• Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study.
  Journal of Clinical Oncology, 1991
• Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (A Gynecologic Oncology Group Study)
  American Journal of Obstetrics and Gynecology, 1989
• Cisplatin as Second-Line Chemotherapy in the Treatment of Advanced or Recurrent Leiomyosarcoma of the Uterus A Phase II Trial of the Gynecologic Oncology Group
  American Journal of Clinical Oncology, 1986
• Treatment of recurrent or advanced uterine sarcoma. A randomized trial of doxorubicinVersus doxorubicin and cyclophosphamide (a phase III trial of the gynecologic oncology group)
  Cancer, 1985
• Surgery for Pulmonary Metastasis: A 20-Year Experience
  The Annals of Thoracic Surgery, 1984
• A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas
  Cancer, 1983